1. Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans.
- Author
-
Howard, Megan, Ledoux, Tracey, Llaneza, Danielle, Taylor, Ashley, Sattem, Evan, and Menefee, Deleene S.
- Subjects
- *
COMPETENCY assessment (Law) , *ANXIETY diagnosis , *DIAGNOSIS of post-traumatic stress disorder , *DIAGNOSIS of mental depression , *MENTAL illness drug therapy , *EDUCATION of veterans , *ANTIDEPRESSANTS , *SUICIDE , *MATERNAL health services , *RETROSPECTIVE studies , *PSYCHOLOGY of veterans , *TREATMENT effectiveness , *RISK assessment , *PATIENT monitoring , *RESEARCH funding , *MEDICAL prescriptions , *TERMINATION of treatment , *ELECTRONIC health records , *COMORBIDITY , *PREGNANCY - Abstract
US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation among pregnant veterans (PGVets). The electronic health records (EHR) of PGVets using the US Veterans Administration's (VA) maternity care benefits over a two-year period were retrospectively reviewed. Inclusion criteria for this study were a current MH diagnosis of depression, anxiety, or posttraumatic stress disorder (PTSD) at the onset of pregnancy (n=351). Outcomes examined included antidepressant use prior to pregnancy, the use and discontinuation of antidepressants during pregnancy, and risk factors for discontinuation. PGVets had a high MH burden, as indicated by multiple comorbid diagnoses of unipolar depression, anxiety, and PTSD in 67% of the sample. At the onset of pregnancy, 163 (46%) were treated with an antidepressant. Only 56 (34%) continued using antidepressants through the pregnancy. Self-discontinuation (34%) and VA provider discontinuation (31%) of antidepressants were found. Among PGVets with documented past suicidal behaviors, 90% discontinued their active antidepressants. PGVets with indicators for more severe MH diagnoses were most likely to discontinue. The MH burden of PGVets and high rates of antidepressant discontinuation have implications for engaging this population in a higher level of perinatal monitoring and intervention. The findings suggest that VA providers and veterans would benefit from risks and benefits education regarding antidepressant use during pregnancy as well as the provision of alternative therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF